Abstract 60: Heparan sulfate proteoglycans can mediate cancer cell oriented migration through integrin independent Rac 1 activation
Abstract Cancer cell membranes and tumor associated extracellular matrix are characterized by a predominant presence of highly sulfated Heparan Sulfate Proteoglycans (HSPGs), which have already been identified as potential tumor markers in different cancers. We previously reported on stable tetra-br...
Saved in:
Published in | Cancer research (Chicago, Ill.) Vol. 79; no. 13_Supplement; p. 60 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.07.2019
|
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Cancer cell membranes and tumor associated extracellular matrix are characterized by a predominant presence of highly sulfated Heparan Sulfate Proteoglycans (HSPGs), which have already been identified as potential tumor markers in different cancers.
We previously reported on stable tetra-branched peptides named NT4, which selectively bind different human cancer tissues and cells, thanks to their high affinity binding to sulfated glycosaminoglycans (GAGs). Using drug-conjugated NT4 peptides as selective tumor targeting agents, we obtained a significant reduction in tumor growth, compared with animals treated with the unconjugated drug under identical conditions. Drug-conjugated NT4 can also by-pass drug resistance mediated by membrane transporters (1-8).
Besides being potential tumor markers, HSPG are also interesting potential drug targets since they appear to take part in many crucial events of cancer progression, such as epithelial mesenchymal transition, migration and invasion.
We identified a putative sulfated oligosaccharide motif allowing high-affinity binding of NT4 to sulfated GAGs. NT4 was then used as a specific tool to analyze the role of sulfated GAGs in signaling events regulating oriented cancer cell migration.
NT4 binding exerts different effects on adhesion and migration in different cancer cells. In PANC-1 human pancreatic adenocarcinoma cells, NT4 binding to sulfated GAGs abolishes cell adhesion and dramatically affects directional migration, inducing disorganization of actin filaments and stress fibers and increasing the number filopodia. This occurs without any effect on activation of beta1 integrins or focal adhesion kinase, but with a clear reduction in Rac1 activity. Otherwise, in TE-671 human rhabdomyosarcoma cells, binding of NT4 to sulfated GAGs has little effect on cell adhesion and cell migration. Untreated TE671 have a slow and scarcely oriented migration and a general morphology which recalls that assumed by PANC-1 upon treatment with NT4, with many filopodia and scarcely organized stress fibers. Interestingly, activated Rac1 is not detectable in untreated migrating TE671 cells. PANC-1 and TE671 have a very different expression of syndecans, particularly syndecan 2 and syndecan 4.
Our results suggest that HSPGs can work as primary players in directional cell migration and actin filaments assembly, by regulating Rac1 activity through an integrin-independent signaling pathway, which seems to require the expression of syndecan 4.
1. Falciani C et al Mol. Cancer Ther. 2007; 6:2441−2448.
2. Falciani C et al ChemMedChem. 2010; 5:567−574.
3. Falciani C et al Curr. Cancer Drug Targets. 2010; 10:695−704.
4. Falciani C et a. ChemMedChem. 2011; 6:678−685.
5. Falciani C et al J Med Chem. 2013; 56:5009-18.
6. Brunetti J et al Sci Rep. 2016; 6:27174.
7. Brunetti J et al Sci Rep. 2015; 5:17736.
8. Depau L et al Oncotarget. 2017; 8:76141-76152.
Note: This abstract was not presented at the meeting.
Citation Format: Luisa Bracci, Lorenzo Depau, Jlenia Brunetti, Giulia Riolo, Elisabetta Mandarini, Marta Zanchi, Fabrizia Zevolini, Alessandro Pini, Chiara Falciani. Heparan sulfate proteoglycans can mediate cancer cell oriented migration through integrin independent Rac 1 activation [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 60. |
---|---|
AbstractList | Abstract
Cancer cell membranes and tumor associated extracellular matrix are characterized by a predominant presence of highly sulfated Heparan Sulfate Proteoglycans (HSPGs), which have already been identified as potential tumor markers in different cancers.
We previously reported on stable tetra-branched peptides named NT4, which selectively bind different human cancer tissues and cells, thanks to their high affinity binding to sulfated glycosaminoglycans (GAGs). Using drug-conjugated NT4 peptides as selective tumor targeting agents, we obtained a significant reduction in tumor growth, compared with animals treated with the unconjugated drug under identical conditions. Drug-conjugated NT4 can also by-pass drug resistance mediated by membrane transporters (1-8).
Besides being potential tumor markers, HSPG are also interesting potential drug targets since they appear to take part in many crucial events of cancer progression, such as epithelial mesenchymal transition, migration and invasion.
We identified a putative sulfated oligosaccharide motif allowing high-affinity binding of NT4 to sulfated GAGs. NT4 was then used as a specific tool to analyze the role of sulfated GAGs in signaling events regulating oriented cancer cell migration.
NT4 binding exerts different effects on adhesion and migration in different cancer cells. In PANC-1 human pancreatic adenocarcinoma cells, NT4 binding to sulfated GAGs abolishes cell adhesion and dramatically affects directional migration, inducing disorganization of actin filaments and stress fibers and increasing the number filopodia. This occurs without any effect on activation of beta1 integrins or focal adhesion kinase, but with a clear reduction in Rac1 activity. Otherwise, in TE-671 human rhabdomyosarcoma cells, binding of NT4 to sulfated GAGs has little effect on cell adhesion and cell migration. Untreated TE671 have a slow and scarcely oriented migration and a general morphology which recalls that assumed by PANC-1 upon treatment with NT4, with many filopodia and scarcely organized stress fibers. Interestingly, activated Rac1 is not detectable in untreated migrating TE671 cells. PANC-1 and TE671 have a very different expression of syndecans, particularly syndecan 2 and syndecan 4.
Our results suggest that HSPGs can work as primary players in directional cell migration and actin filaments assembly, by regulating Rac1 activity through an integrin-independent signaling pathway, which seems to require the expression of syndecan 4.
1. Falciani C et al Mol. Cancer Ther. 2007; 6:2441−2448.
2. Falciani C et al ChemMedChem. 2010; 5:567−574.
3. Falciani C et al Curr. Cancer Drug Targets. 2010; 10:695−704.
4. Falciani C et a. ChemMedChem. 2011; 6:678−685.
5. Falciani C et al J Med Chem. 2013; 56:5009-18.
6. Brunetti J et al Sci Rep. 2016; 6:27174.
7. Brunetti J et al Sci Rep. 2015; 5:17736.
8. Depau L et al Oncotarget. 2017; 8:76141-76152.
Note: This abstract was not presented at the meeting.
Citation Format: Luisa Bracci, Lorenzo Depau, Jlenia Brunetti, Giulia Riolo, Elisabetta Mandarini, Marta Zanchi, Fabrizia Zevolini, Alessandro Pini, Chiara Falciani. Heparan sulfate proteoglycans can mediate cancer cell oriented migration through integrin independent Rac 1 activation [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 60. |
Author | Falciani, Chiara Bracci, Luisa Mandarini, Elisabetta Zanchi, Marta Riolo, Giulia Depau, Lorenzo Brunetti, Jlenia Zevolini, Fabrizia Pini, Alessandro |
Author_xml | – sequence: 1 givenname: Luisa surname: Bracci fullname: Bracci, Luisa – sequence: 2 givenname: Lorenzo surname: Depau fullname: Depau, Lorenzo – sequence: 3 givenname: Jlenia surname: Brunetti fullname: Brunetti, Jlenia – sequence: 4 givenname: Giulia surname: Riolo fullname: Riolo, Giulia – sequence: 5 givenname: Elisabetta surname: Mandarini fullname: Mandarini, Elisabetta – sequence: 6 givenname: Marta surname: Zanchi fullname: Zanchi, Marta – sequence: 7 givenname: Fabrizia surname: Zevolini fullname: Zevolini, Fabrizia – sequence: 8 givenname: Alessandro surname: Pini fullname: Pini, Alessandro – sequence: 9 givenname: Chiara surname: Falciani fullname: Falciani, Chiara |
BookMark | eNo9kN1KAzEQhYNUsK0-gTd5ga353R_vSlErVATp_ZJNZreRbbIkqdBrX9xdK96cOXNmmIFvgWbOO0DonpIVpbJ8oJKXWSGEXK3fGKFVlpMrNP9PZ2hOCCkzKQp2gxYxfo6tpETO0fe6iSkonXBOHvEWBhWUw_HUtyoBHoJP4Lv-rJWLeBR8BGOnyeg1BKyh77EPFlwCg4-2CypZ73A6BH_qDtiOeResG42BAUZxCX8ojSkef9qv3-1bdN2qPsLdX12i_fPTfrPNdu8vr5v1LtNlRTImtFCgdMGLHJiqKto0TDScAaeiBdkaSYxocsOINqCgkLQt88oQXkktteBLxC9ndfAxBmjrIdijCueaknrCWE_A6glYfcFY54T_ALUDamo |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.1158/1538-7445.AM2019-60 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1538-7445 |
EndPage | 60 |
ExternalDocumentID | 10_1158_1538_7445_AM2019_60 |
GroupedDBID | --- -ET 18M 29B 2WC 34G 39C 476 53G 5GY 5RE 5VS 6J9 AAYXX ABOCM ACGFO ACIWK ACPRK ACSVP ADBBV ADCOW ADNWM AENEX AFHIN AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CITATION CS3 DIK DU5 EBS EJD F5P FRP GX1 H13 IH2 KQ8 L7B LSO OK1 P0W P2P PQQKQ RCR RHF RHI RNS SJN TR2 W2D W8F WH7 WOQ YKV YZZ |
ID | FETCH-LOGICAL-c890-24c4aeac7376e2a991bb24b32e314fe5fd50d4b6d20cdeae751f869d0395c5c43 |
ISSN | 0008-5472 |
IngestDate | Thu Sep 26 17:50:45 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 13_Supplement |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c890-24c4aeac7376e2a991bb24b32e314fe5fd50d4b6d20cdeae751f869d0395c5c43 |
OpenAccessLink | https://doi.org/10.1158/1538-7445.am2019-60 |
PageCount | 1 |
ParticipantIDs | crossref_primary_10_1158_1538_7445_AM2019_60 |
PublicationCentury | 2000 |
PublicationDate | 2019-07-01 |
PublicationDateYYYYMMDD | 2019-07-01 |
PublicationDate_xml | – month: 07 year: 2019 text: 2019-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationTitle | Cancer research (Chicago, Ill.) |
PublicationYear | 2019 |
SSID | ssj0005105 |
Score | 2.3438127 |
Snippet | Abstract
Cancer cell membranes and tumor associated extracellular matrix are characterized by a predominant presence of highly sulfated Heparan Sulfate... |
SourceID | crossref |
SourceType | Aggregation Database |
StartPage | 60 |
Title | Abstract 60: Heparan sulfate proteoglycans can mediate cancer cell oriented migration through integrin independent Rac 1 activation |
Volume | 79 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiEuK57iLR-4hRQ3cZyUW3mpLCoHVKS9RbHj7FYKCeomSOyVn8gfYsaPJMAKsVys1kqnTubTjMf5ZoaQp7Cl0GAZo5CVUQUBimBhJnkZIl5SnemCZ5jvvPkg1p_40XFyPJv9mLCW-k7O1fmFeSX_o1WYA71iluwlNDsIhQn4DPqFETQM4z_peCXxoEJ1gWAY2a81FvJukHFewRYyMDUY2pP6Gzw-rEHd2DyRzlC9lN4HeGoftFjpGPedn3cnDg6-eY-tJbFDMqRvltsFHwsVLEwNjq-jVsdaByjXVRA6Na-ILdfD2KK6nk9OHl7C0pVNzu53Z4N7eA130ZvZdq-b83a8vG90Z9kHRzVyBIeXRZhyYw74d33tpt1Bhsmd8gcZ3jhnYcJtJ5-5Hu1xym3FSW-wbfcZD8w4N_1PR6KQtcS2S4Hz6fbLn94iwQyI4T_mq41Zl__ptDb3bz5zYDKaGCrJchSSo5DcCskFu0KuRmD9DHfg3fuRd-R4tf5uXSksEPL8gpVMtkuTfc_2Bjl0AQtdWfTdJDPd3CLXNo6ScZt89yCkgr2gDoLUQZD-AkEKA3UQpBaCFCFIPQTpAEHqIEg9BOkEghQgSBd0hOAdsn37ZvtqHbrOHqHKliyMuOIFePwUvJuOCghRpIy4jCMdL3ilk6pMWMmlKCOmSl3oNFlUmViWLF4mKlE8vksOmrbR9wjNhJCsKmIhITCWUkMUVvAFJoRjbpxK75Nn_vnlX2z9lvwvOntwucsfkusjkh-Rg27f68ewSe3kE6P0n8xxkDc |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Abstract+60%3A+Heparan+sulfate+proteoglycans+can+mediate+cancer+cell+oriented+migration+through+integrin+independent+Rac+1+activation&rft.jtitle=Cancer+research+%28Chicago%2C+Ill.%29&rft.au=Bracci%2C+Luisa&rft.au=Depau%2C+Lorenzo&rft.au=Brunetti%2C+Jlenia&rft.au=Riolo%2C+Giulia&rft.date=2019-07-01&rft.issn=0008-5472&rft.eissn=1538-7445&rft.volume=79&rft.issue=13_Supplement&rft.spage=60&rft.epage=60&rft_id=info:doi/10.1158%2F1538-7445.AM2019-60&rft.externalDBID=n%2Fa&rft.externalDocID=10_1158_1538_7445_AM2019_60 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-5472&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-5472&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-5472&client=summon |